{"id":"intensive-antiplatelet","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding"},{"rate":null,"effect":"Gastrointestinal hemorrhage"},{"rate":null,"effect":"Intracranial hemorrhage"}]},"_chembl":{"chemblId":"CHEMBL634","moleculeType":"Small molecule","molecularWeight":"416.53"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This approach typically combines two or more antiplatelet agents (such as aspirin and P2Y12 inhibitors) to provide enhanced inhibition of platelet function through different mechanisms. By blocking multiple pathways of platelet activation and aggregation, intensive antiplatelet regimens aim to reduce the risk of thrombotic complications in high-risk cardiovascular patients.","oneSentence":"Intensive antiplatelet therapy inhibits platelet aggregation through multiple pathways to reduce thrombotic events.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:16:22.981Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome"},{"name":"Secondary prevention of thrombotic events in high-risk patients"}]},"trialDetails":[{"nctId":"NCT07002476","phase":"PHASE3","title":"Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion","status":"RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2025-06-19","conditions":"Stroke","enrollment":652},{"nctId":"NCT07290699","phase":"PHASE4","title":"Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital of Nanchang University","startDate":"2026-01-01","conditions":"STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)","enrollment":2442},{"nctId":"NCT05300737","phase":"","title":"Symptomatic Carotid Outcomes Registry","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2022-08-01","conditions":"Carotid Stenosis, Ischemic Stroke, Transient Ischemic Attack","enrollment":114},{"nctId":"NCT07121088","phase":"PHASE4","title":"Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study","status":"NOT_YET_RECRUITING","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2025-08-31","conditions":"Ischemic Cerebral Infarction, Diabetes Mellitus","enrollment":3666},{"nctId":"NCT07088523","phase":"PHASE4","title":"Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study","status":"NOT_YET_RECRUITING","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2025-07-31","conditions":"Diabete Mellitus, Ischemic Cardiovascular Disease","enrollment":4205},{"nctId":"NCT05349955","phase":"NA","title":"Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2022-11-21","conditions":"Type 2 Diabetes, Cardiovascular Complication, Diabetic Kidney Disease","enrollment":5600},{"nctId":"NCT03551964","phase":"PHASE4","title":"Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction","status":"COMPLETED","sponsor":"Faculty Hospital Kralovske Vinohrady","startDate":"2018-08-01","conditions":"Acute Myocardial Infarction, Cardiogenic Shock","enrollment":605},{"nctId":"NCT06899399","phase":"NA","title":"Efficacy and Safety Study of Endovascular Treatment of Asymptomatic Carotid Artery Stenosis","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-10-18","conditions":"Asymptomatic Carotid Artery Stenosis","enrollment":982},{"nctId":"NCT04824911","phase":"PHASE2","title":"Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-03-23","conditions":"Acute Stroke, Dual Antiplatelet Therapy, Statin","enrollment":376},{"nctId":"NCT06082063","phase":"PHASE3","title":"Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes","status":"RECRUITING","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2024-07-01","conditions":"Cardiovascular Diseases, Heart Failure, Type 1 Diabetes","enrollment":2000},{"nctId":"NCT05058469","phase":"","title":"Tracheotomy With and Without Dual Antiplatelet Therapy","status":"UNKNOWN","sponsor":"Asklepios Neurological Clinic Bad Salzhausen","startDate":"2022-10-01","conditions":"Tracheostomy Hemorrhage","enrollment":300},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04140110","phase":"NA","title":"Second Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED2)","status":"TERMINATED","sponsor":"The George Institute for Global Health, China","startDate":"2020-07-20","conditions":"Acute Ischemic Stroke","enrollment":816},{"nctId":"NCT05996978","phase":"","title":"Intensive Drug Therapy for Ischemic Stroke Caused by Severe Intracranial Arterial Stenosis","status":"COMPLETED","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2020-02-01","conditions":"Ischemic Stroke","enrollment":42},{"nctId":"NCT03635749","phase":"PHASE3","title":"Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2018-09-17","conditions":"Acute Stroke, Transient Ischemic Attack","enrollment":6100},{"nctId":"NCT05690542","phase":"","title":"Nanoparticles in Blood: Understanding and Controlling Protein Corona for Optimized Nanomedicine","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2023-02","conditions":"Coagulation Tests","enrollment":60},{"nctId":"NCT05620615","phase":"","title":"Intensive Drug Therapy for Ischemic Stroke","status":"UNKNOWN","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2018-07-01","conditions":"Ischemic Stroke","enrollment":42},{"nctId":"NCT00535925","phase":"PHASE4","title":"Nephropathy In Type 2 Diabetes and Cardio-renal Events","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2005-10","conditions":"Diabetic Nephropathy","enrollment":850},{"nctId":"NCT03818451","phase":"NA","title":"Co-ultra PEALut Enhances Neuronal Recovery Following Moderate Traumatic Brain Injury","status":"UNKNOWN","sponsor":"University of Messina","startDate":"2016-05-01","conditions":"Traumatic Brain Injury","enrollment":60},{"nctId":"NCT01661322","phase":"PHASE3","title":"Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke","status":"TERMINATED","sponsor":"University of Nottingham","startDate":"2009-04","conditions":"Stroke","enrollment":3096},{"nctId":"NCT03372330","phase":"","title":"Peripheral Artery Disease and Sepsis Outcomes","status":"UNKNOWN","sponsor":"National Taiwan University Hospital Hsin-Chu Branch","startDate":"2017-09-11","conditions":"Peripheral Artery Disease, Peripheral Artery Occlusion, Sepsis","enrollment":200},{"nctId":"NCT00241904","phase":"PHASE4","title":"Reducing Total Cardiovascular Risk in an Urban Community","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2006-05","conditions":"Cardiovascular Diseases, Heart Diseases, Coronary Disease","enrollment":525},{"nctId":"NCT01094457","phase":"PHASE4","title":"Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation","status":"COMPLETED","sponsor":"Shenyang Northern Hospital","startDate":"2009-03","conditions":"Acute Coronary Syndromes, Percutaneous Coronary Intervention, Clopidogrel Low Responsiveness","enrollment":840}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":56,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Dual antiplatelet"],"phase":"phase_3","status":"active","brandName":"Intensive antiplatelet","genericName":"Intensive antiplatelet","companyName":"Beijing Tiantan Hospital","companyId":"beijing-tiantan-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"There is no verified information about intensive antiplatelet therapy in the provided facts. However, based on the information, Aspirin is a small molecule (ChEMBL) and has been studied as an intervention for various conditions, including Cardiovascular Diseases and Stroke, on ClinicalTrials.gov.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}